Second-line axicabtagene ciloleucel in large B-cell lymphoma ineligible for transplantation: ALYCANTE final analysis. (PubMed, Hemasphere) - Sep 24, 2026 - No abstract available
Journal • B Cell Lymphoma • Hematological Malignancies • Large B Cell Lymphoma • Lymphoma • Non-Hodgkin's Lymphoma • Oncology • Transplantation
|
|
Alexis Claudel; Camille Laurent; Catherine Thieblemont; Cédric Portugues; Clément Bailly; Emmanuel Bachy; Emmanuel Itti; Fabrice Jardin; Francisco Llamas-Gutierrez; Franck Morschhauser; François Lemonnier; François-Xavier Gros; Gabriel Brisou; Guillaume Cartron; Jacques-Olivier Bay; Jean Lemoine; Jules Coville; Karin Tarte; Lucie Oberic; Magalie Joris; Morgane Cheminant; Olivier Casasnovas; Paul Blanc-Durand; Pierre Feugier; Rémy Duléry; Roch Houot; Sylvain Choquet; Thomas Gastinne; Xavier Palard-Novello; Yassine Al Tabaa
|